Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$19.47 - $28.49 $16,062 - $23,504
-825 Reduced 2.27%
35,481 $806,000
Q4 2022

Feb 13, 2023

SELL
$18.08 - $30.0 $172,483 - $286,200
-9,540 Reduced 20.81%
36,306 $854,000
Q2 2022

Aug 11, 2022

SELL
$16.0 - $45.99 $964,064 - $2.77 Million
-60,254 Reduced 56.79%
45,846 $1.01 Million
Q1 2022

May 11, 2022

SELL
$33.17 - $46.98 $97,188 - $137,651
-2,930 Reduced 2.69%
106,100 $4.76 Million
Q4 2021

Feb 14, 2022

BUY
$39.06 - $67.58 $778,856 - $1.35 Million
19,940 Added 22.38%
109,030 $4.67 Million
Q3 2021

Nov 10, 2021

BUY
$60.13 - $77.6 $293,795 - $379,153
4,886 Added 5.8%
89,090 $5.92 Million
Q2 2021

Aug 13, 2021

BUY
$50.07 - $76.78 $211,495 - $324,318
4,224 Added 5.28%
84,204 $6.18 Million
Q1 2021

May 12, 2021

BUY
$58.92 - $97.33 $2.07 Million - $3.42 Million
35,140 Added 78.37%
79,980 $5.48 Million
Q4 2020

Feb 10, 2021

SELL
$43.6 - $73.05 $59,296 - $99,348
-1,360 Reduced 2.94%
44,840 $3.01 Million
Q3 2020

Nov 12, 2020

BUY
$38.47 - $52.03 $437,211 - $591,320
11,365 Added 32.63%
46,200 $2.38 Million
Q2 2020

Aug 12, 2020

BUY
$27.28 - $43.01 $950,298 - $1.5 Million
34,835 New
34,835 $1.31 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $726M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.